86 related articles for article (PubMed ID: 28978661)
1. Studies on Para-Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications.
Vevelstad M; Øiestad EL; Nerem E; Arnestad M; Bogen IL
Drug Metab Dispos; 2017 Dec; 45(12):1326-1335. PubMed ID: 28978661
[TBL] [Abstract][Full Text] [Related]
2. Is toxicity of PMMA (paramethoxymethamphetamine) associated with cytochrome P450 pharmacogenetics?
Vevelstad M; Øiestad EL; Bremer S; Bogen IL; Zackrisson AL; Arnestad M
Forensic Sci Int; 2016 Apr; 261():137-47. PubMed ID: 26930544
[TBL] [Abstract][Full Text] [Related]
3. Identification of human cytochrome P450 2D6 as major enzyme involved in the O-demethylation of the designer drug p-methoxymethamphetamine.
Staack RF; Theobald DS; Paul LD; Springer D; Kraemer T; Maurer HH
Drug Metab Dispos; 2004 Apr; 32(4):379-81. PubMed ID: 15039289
[TBL] [Abstract][Full Text] [Related]
4. Studies on distribution of para-methoxymethamphetamine (PMMA) designer drug in rats using gas chromatography-mass spectrometry.
Rohanova M; Balikova M
Leg Med (Tokyo); 2009 Apr; 11 Suppl 1():S429-30. PubMed ID: 19261515
[TBL] [Abstract][Full Text] [Related]
5. Studies on distribution and metabolism of para-methoxymethamphetamine (PMMA) in rats after subcutaneous administration.
Rohanova M; Balikova M
Toxicology; 2009 May; 259(1-2):61-8. PubMed ID: 19428944
[TBL] [Abstract][Full Text] [Related]
6. CYP2D6 polymorphism is not crucial for the disposition of selegiline.
Scheinin H; Anttila M; Dahl ML; Karnani H; Nyman L; Taavitsainen P; Pelkonen O; Bertilsson L
Clin Pharmacol Ther; 1998 Oct; 64(4):402-11. PubMed ID: 9797797
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes.
Zhu M; Zhao W; Jimenez H; Zhang D; Yeola S; Dai R; Vachharajani N; Mitroka J
Drug Metab Dispos; 2005 Apr; 33(4):500-7. PubMed ID: 15640381
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Atomoxetine Biotransformation and Implications for Development of PBPK Models for Dose Individualization in Children.
Dinh JC; Pearce RE; Van Haandel L; Gaedigk A; Leeder JS
Drug Metab Dispos; 2016 Jul; 44(7):1070-9. PubMed ID: 27052878
[TBL] [Abstract][Full Text] [Related]
9. Three fatal cases of PMA and PMMA poisoning in Denmark.
Johansen SS; Hansen AC; Müller IB; Lundemose JB; Franzmann MB
J Anal Toxicol; 2003; 27(4):253-6. PubMed ID: 12820749
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.
Haufroid V; Hantson P
Clin Toxicol (Phila); 2015 Jul; 53(6):501-10. PubMed ID: 25998998
[TBL] [Abstract][Full Text] [Related]
11. Timolol metabolism in human liver microsomes is mediated principally by CYP2D6.
Volotinen M; Turpeinen M; Tolonen A; Uusitalo J; Mäenpää J; Pelkonen O
Drug Metab Dispos; 2007 Jul; 35(7):1135-41. PubMed ID: 17431033
[TBL] [Abstract][Full Text] [Related]
12. Enhanced methamphetamine metabolism in rhesus macaque as compared with human: an analysis using a novel method of liquid chromatography with tandem mass spectrometry, kinetic study, and substrate docking.
Earla R; Kumar S; Wang L; Bosinger S; Li J; Shah A; Gangwani M; Nookala A; Liu X; Cao L; Jackson A; Silverstein PS; Fox HS; Li W; Kumar A
Drug Metab Dispos; 2014 Dec; 42(12):2097-108. PubMed ID: 25301936
[TBL] [Abstract][Full Text] [Related]
13. Irreversible inhibition of CYP2D6 by (-)-chloroephedrine, a possible impurity in methamphetamine.
Rege B; Carter KM; Sarkar MA; Kellogg GE; Soine WH
Drug Metab Dispos; 2002 Dec; 30(12):1337-43. PubMed ID: 12433800
[TBL] [Abstract][Full Text] [Related]
14. In vitro metabolism and pharmacokinetic studies on methylone.
Pedersen AJ; Petersen TH; Linnet K
Drug Metab Dispos; 2013 Jun; 41(6):1247-55. PubMed ID: 23545806
[TBL] [Abstract][Full Text] [Related]
15. The PMMA epidemic in Norway: comparison of fatal and non-fatal intoxications.
Vevelstad M; Øiestad EL; Middelkoop G; Hasvold I; Lilleng P; Delaveris GJ; Eggen T; Mørland J; Arnestad M
Forensic Sci Int; 2012 Jun; 219(1-3):151-7. PubMed ID: 22257968
[TBL] [Abstract][Full Text] [Related]
16. 3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.
Zhen Y; Slanar O; Krausz KW; Chen C; Slavík J; McPhail KL; Zabriskie TM; Perlík F; Gonzalez FJ; Idle JR
Drug Metab Dispos; 2006 Sep; 34(9):1563-74. PubMed ID: 16782768
[TBL] [Abstract][Full Text] [Related]
17. Comparative metabolic study between two selective estrogen receptor modulators, toremifene and tamoxifen, in human liver microsomes.
Watanabe M; Watanabe N; Maruyama S; Kawashiro T
Drug Metab Pharmacokinet; 2015 Oct; 30(5):325-33. PubMed ID: 26423799
[TBL] [Abstract][Full Text] [Related]
18. Severe paramethoxymethamphetamine (PMMA) and paramethoxyamphetamine (PMA) outbreak in Israel.
Lurie Y; Gopher A; Lavon O; Almog S; Sulimani L; Bentur Y
Clin Toxicol (Phila); 2012 Jan; 50(1):39-43. PubMed ID: 22148985
[TBL] [Abstract][Full Text] [Related]
19. Selective inhibition of the cytochrome P450 isoform by hyperoside and its potent inhibition of CYP2D6.
Song M; Hong M; Lee MY; Jee JG; Lee YM; Bae JS; Jeong TC; Lee S
Food Chem Toxicol; 2013 Sep; 59():549-53. PubMed ID: 23835282
[TBL] [Abstract][Full Text] [Related]
20. Determination of 4-hydroxy-3-methoxymethamphetamine as a metabolite of methamphetamine in rats and human liver microsomes using gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry.
Kuwayama K; Tsujikawa K; Miyaguchi H; Kanamori T; Iwata YT; Inoue H
J Anal Toxicol; 2009 Jun; 33(5):266-71. PubMed ID: 19671246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
